Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2012
06/12/2012US8198270 Compounds for proteasome enzyme inhibition
06/12/2012US8198269 Fused aminodihydrothiazine derivative
06/12/2012US8198268 Tianeptine sulfate salt forms and methods of making and using the same
06/12/2012US8198267 Substituted oxazolidinones and their use
06/12/2012US8198266 Use of an EGFR antagonist for the treatment of glomerolonephritis
06/12/2012US8198265 Regulation of T cell-mediated immunity by tryptophan
06/12/2012US8198264 Method for treating head and neck cancer
06/12/2012US8198263 Vitamin D derivatives active on the vitamin D nuclear receptor, preparation and uses thereof
06/12/2012US8198262 Methods for treating multiple myeloma using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione
06/12/2012US8198261 Thermally modified microbial-derived cellulose for in vivo implantation
06/12/2012US8198260 Composition for the prevention and/or treatment of disorders due to abnormal lipid metabolism, comprising propionyl L-carnitine and chitosan
06/12/2012US8198259 Treatment of neurological disorders by dsRNA administration
06/12/2012US8198258 Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases
06/12/2012US8198255 SiRNA-mediated inhibition of doublecortin and Ca2+/calmodulin-dependent kinase-like-1
06/12/2012US8198253 Compositions and their uses directed to HBXIP
06/12/2012US8198249 Methods and compositions for the treatment of obesity, insulin related diseases and hypercholesterolemia
06/12/2012US8198248 Formulations for nonsurgical exogenous crosslink therapy
06/12/2012US8198245 Compositions and methods for soft tissue augmentation
06/12/2012US8198239 Methods for treating wounds
06/12/2012US8198238 Flowable carrier matrix and methods for delivering to a patient
06/12/2012US8198234 Methods of suppressing microglial activation
06/12/2012US8198233 Synthetic peptides that enhance tight junction permeability
06/12/2012US8197871 Composition for headache treatment
06/12/2012US8197867 Dietary supplement system
06/12/2012US8197858 Use of calcitonin, SERMs such as raloxifene, testosterone, estrogen, calcimimetics such as cinacalcet, RANKL inhibitors such as denosumab, and bisphosphonates such as risedronate
06/12/2012US8197855 Compositions and methods for nutrition supplementation
06/12/2012US8197854 Nutritional supplement for use under physiologically stressful conditions
06/12/2012US8197850 increase in the time corresponding to the plasma concentration maximum, without a very significant decrease in the bioavailability; comprises several thousand anti-hyperglycaemic (metformin) microcapsules; drug core with coating film
06/12/2012US8197849 Cross-linked oxidated hyaluronic acid for use as a vitreous substitute
06/12/2012US8197848 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
06/12/2012US8197846 Sustained release pharmaceutical composition
06/12/2012US8197845 Encapsulated tiotropium containing powder formulation for inhalation
06/12/2012US8197843 Device for the administration of an active agent to the human skin
06/12/2012US8197839 A miniature coated tablet or covered rod implant; smaller size and larger payloads than immediate release tablets; veterinary medicine
06/12/2012US8197838 Sustained release systems of ascorbic acid phosphate
06/12/2012US8197825 Recombinant MVA virus and the use thereof
06/12/2012US8197813 Human antibodies that bind human TNFα
06/12/2012US8197807 Nucleotide sequences coding muscle specific integrin binding protein for use as tool in targeting cancer cells for destruction
06/12/2012US8197803 Method of forming a conformable solvent-based bandage and coating material
06/12/2012US8197802 Method for treating or inhibiting the formation of adhesions following surgery or injury
06/12/2012CA2681962C Methods of administering epothilone analogs for the treatment of cancer
06/12/2012CA2663965C Pyrazolopyrimidine derivative and use thereof as an anticancer agent
06/12/2012CA2662242C Benzo-fused compounds for use in treating metabolic disorders
06/12/2012CA2659471C Novel crystals of substituted phenylalkanoic acid and method of producing the same
06/12/2012CA2658523C Inhibitors of plasma kallikrein
06/12/2012CA2647596C Pyrrolo- and thiazolo-pyridine compounds as hif modulators
06/12/2012CA2641564C Use of kcnq-openers for treating or reducing the symptoms of schizophrenia
06/12/2012CA2591157C Antibiotic combinations for providing total solution to the treatment of infections
06/12/2012CA2560897C Macrocyclic compounds as inhibitors of viral replication
06/12/2012CA2481486C Multi-phase, multi-compartment capsular system
06/12/2012CA2479549C Novel crystal form of 5-hydroxy-1-methylhydantoin
06/12/2012CA2475331C Synthesis of indole thiazole compounds as ligands for the ah receptor
06/12/2012CA2413251C Compositions and methods to improve the oral absorption of antimicrobial agents
06/12/2012CA2408323C Drug delivery systems for photodynamic therapy
06/12/2012CA2363269C Dna vaccination for treatment of autoimmune disease
06/12/2012CA2262756C A tumor necrosis factor related ligand
06/12/2012CA2249746C Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis
06/12/2012CA2214830C Nucleotide and protein sequences of vertebrate serrate genes and methods based thereon
06/07/2012WO2012075500A2 7-deazapurine modulators of histone methyltransferase, and methods of use thereof
06/07/2012WO2012075492A2 Carbocycle-substituted purine and 7-deazapurine compounds
06/07/2012WO2012075484A2 Novel drug targets to overcome de novo drug-resistance in multiple myeloma
06/07/2012WO2012075473A1 Preparation and use of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane in the treatment of conditions affected by monoamine neurotransmitters
06/07/2012WO2012075459A1 Increasing drug bioavailability in naltrexone therapy
06/07/2012WO2012075456A1 Bromodomain inhibitors and uses thereof
06/07/2012WO2012075453A1 Methods for reducing binge or compulsive eating
06/07/2012WO2012075451A2 Clonidine and gaba compounds in a biodegradable polymer carrier
06/07/2012WO2012075447A2 Compositions and methods for delivering clonidine and bupivacaine to a target tissue site
06/07/2012WO2012075443A2 Methods for delivering clonidine compositions in a biodegradable polymer carrier and local steriods to a target tissue site
06/07/2012WO2012075396A2 Prodrugs of 6-cyclohexyl-1-hydroxy-4- methylpyridin-2(1h)-one and derivatives thereof
06/07/2012WO2012075393A2 Activators of proteasomal degradation and uses thereof
06/07/2012WO2012075383A2 Bromodomain inhibitors and uses thereof
06/07/2012WO2012075381A1 Substituted purine and 7 - deazapurine compounds as modulators of epigenetic enzymes
06/07/2012WO2012075380A1 Tip60 inhibitors
06/07/2012WO2012075379A2 Liquid viral formulations
06/07/2012WO2012075376A2 Lyophilized viral formulations
06/07/2012WO2012075373A2 Solid dosage form that promotes reliable oral, esophageal and gi transit
06/07/2012WO2012075362A2 Chemokine cxcr4 receptor modulators and used related thereto
06/07/2012WO2012075339A1 Delivery of heparins by microinjection systems
06/07/2012WO2012075327A1 Methods for treating a tumor using an antibody that specifically binds grp94
06/07/2012WO2012075324A1 Methods for treating a tumor using an antibody that specifically binds hmw-maa
06/07/2012WO2012075296A1 Dissolvable pharmaceutical implant
06/07/2012WO2012075288A1 Method of treatment of obsessive compulsive disorder with ondansetron
06/07/2012WO2012075286A2 Intrapulmonary benzodiazepine for the treatment and prevention of seizures
06/07/2012WO2012075257A2 Compositions for oral and nasal hygiene
06/07/2012WO2012075244A2 Use of hemoglobin effectors to increase the bioavailability of therapeutic gases
06/07/2012WO2012075242A2 Controlled chemical release of hydrogen sulfide
06/07/2012WO2012075239A1 Serotonin reuptake inhibitors
06/07/2012WO2012075235A1 Alkyl amides as hiv attachment inhibitors
06/07/2012WO2012075232A1 Opioid receptor ligands and methods of using and making the same
06/07/2012WO2012075211A2 Combination therapy with a gallium complex
06/07/2012WO2012075210A2 Method for treating refractory cancer
06/07/2012WO2012075209A1 Delivery of triptans by microinjection systems
06/07/2012WO2012075174A2 Compounds and methods for skin repair
06/07/2012WO2012075140A1 Compounds
06/07/2012WO2012075115A1 4-substituted-cyclohexylamino-4-piperidinyl-acetamide antagonists of ccr2
06/07/2012WO2012075111A1 Uses of anti-cd40 antibodies in combination therapy for b cell-related cancers
06/07/2012WO2012075107A2 Active enantiomer of dodecyl 2-(n,n-dimethylamino)-propionate
06/07/2012WO2012075093A2 Topical formulations for administration of omega-3 fatty acids
06/07/2012WO2012075081A2 High-strength testosterone undecanoate compositions
06/07/2012WO2012075080A1 Indoles
1 ... 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 ... 7860